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ABSTRACT 
PURPOSE-To study the prevalence of vitamin D deficiency in 
Dysmenorrhea  and to study the role of single oral dose of 3,00,000 IU of vitamin  
D 3 cholecalcifero  to improve primary dysmenorrhea. 
METHODOLOGY: 
  50 patients aged 18 to 25 years old adult females attending the OPD clinics  
with primary dysmenorrhea were enrolled in the study and enquired about their 
ages, BMI, detailed menstrual history, baseline VAS score, regarding the use of 
NSAIDS and baseline serum 25(OH) vitamin D3 level tested. At the end of 6 
months patients will be randomized to receive either a single oral dose of vitamin 
D3  3,00,000 IU(Group A) or Placebo drug Iron tablets(Group B).Patients were  
asked to fill in the VAS score and enquired about usage of  NSADS at the end of 2 
nd and 4 th month after  supplementation .  Vitamin D3 levels were rechecked at 
the end of 2 and 4 months. 
RESULTS: Of the 50 dysmenorrheic women,70 % were found to have vitamin D 
deficiency. Among the vitamin D group ,at the start of the study, mean  vitamin D 
level was around 17.84 ± 10.1,VAS score was 8.76±0.97,NSAID usage was 
around 96 % ,2 months later, mean vitamin D level was 42.64±10.1,VAS score 
was 2.72±1.17,NSAID usage reduced to  8%,4 months later, mean vitamin D level 
was 34.70±8.1,VAS score was 3.56±0.76,NSAID usage was 8% .But no difference 
was noted in the placebo group. 
 
Conclusion  There  is increased prevalence of vitamin D deficiency in 
dysmenorrhea and there is a definite improvement in dysmenorrhea with 
supplementation of vitamin D. 
 
